Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort.
Saved in:
| Title: | Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort. |
|---|---|
| Authors: | Mas, S. (AUTHOR), Gassó, P. (AUTHOR), Rodríguez, N. (AUTHOR), Cabrera, B. (AUTHOR), Mezquida, G. (AUTHOR), Lobo, A. (AUTHOR), González‐Pinto, A. (AUTHOR), Parellada, M. (AUTHOR), Corripio, I. (AUTHOR), Vieta, E. (AUTHOR), Castro‐Fornieles, J. (AUTHOR), Bobes, J. (AUTHOR), Usall, J. (AUTHOR), Saiz‐Ruiz, J. (AUTHOR), Contreras, F. (AUTHOR), Parellada, E. (AUTHOR), Bernardo, M. (AUTHOR), Lafuente, Amalia (AUTHOR), Bioque, Miquel (AUTHOR), Diaz‐Caneja, Covadonga M. (AUTHOR) |
| Source: | Acta Psychiatrica Scandinavica. Jun2020, Vol. 141 Issue 6, p541-552. 12p. 2 Charts, 2 Graphs. |
| Subjects: | Individualized medicine, Psychoses, Phenotypes, Age of onset, Mental illness |
| Abstract: | Aims: Here, we present a clustering strategy to identify phenotypes of antipsychotic (AP) response by using longitudinal data from patients presenting first‐episode psychosis (FEP). Method: One hundred and ninety FEP with complete data were selected from the PEPs project. The efficacy was assessed using total PANSS, and adverse effects using total UKU, during one‐year follow‐up. We used the Klm3D method to cluster longitudinal data. Results: We identified four clusters: cluster A, drug not toxic and beneficial; cluster B, drug beneficial but toxic; cluster C, drug neither toxic nor beneficial; and cluster D, drug toxic and not beneficial. These groups significantly differ in baseline demographics, clinical, and neuropsychological characteristics (PAS, total PANSS, DUP, insight, pIQ, age of onset, cocaine use and family history of mental illness). Conclusions: The results presented here allow the identification of phenotypes of AP response that differ in well‐known simple and classic clinical variables opening the door to clinical prediction and application of personalized medicine. [ABSTRACT FROM AUTHOR] |
| Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 143634107 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mas%2C+S%2E%22">Mas, S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gassó%2C+P%2E%22">Gassó, P.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rodríguez%2C+N%2E%22">Rodríguez, N.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cabrera%2C+B%2E%22">Cabrera, B.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mezquida%2C+G%2E%22">Mezquida, G.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lobo%2C+A%2E%22">Lobo, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22González‐Pinto%2C+A%2E%22">González‐Pinto, A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parellada%2C+M%2E%22">Parellada, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corripio%2C+I%2E%22">Corripio, I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vieta%2C+E%2E%22">Vieta, E.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Castro‐Fornieles%2C+J%2E%22">Castro‐Fornieles, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bobes%2C+J%2E%22">Bobes, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Usall%2C+J%2E%22">Usall, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saiz‐Ruiz%2C+J%2E%22">Saiz‐Ruiz, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Contreras%2C+F%2E%22">Contreras, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parellada%2C+E%2E%22">Parellada, E.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bernardo%2C+M%2E%22">Bernardo, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lafuente%2C+Amalia%22">Lafuente, Amalia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bioque%2C+Miquel%22">Bioque, Miquel</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Diaz‐Caneja%2C+Covadonga+M%2E%22">Diaz‐Caneja, Covadonga M.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Acta+Psychiatrica+Scandinavica%22">Acta Psychiatrica Scandinavica</searchLink>. Jun2020, Vol. 141 Issue 6, p541-552. 12p. 2 Charts, 2 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Individualized+medicine%22">Individualized medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Psychoses%22">Psychoses</searchLink><br /><searchLink fieldCode="DE" term="%22Phenotypes%22">Phenotypes</searchLink><br /><searchLink fieldCode="DE" term="%22Age+of+onset%22">Age of onset</searchLink><br /><searchLink fieldCode="DE" term="%22Mental+illness%22">Mental illness</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Aims: Here, we present a clustering strategy to identify phenotypes of antipsychotic (AP) response by using longitudinal data from patients presenting first‐episode psychosis (FEP). Method: One hundred and ninety FEP with complete data were selected from the PEPs project. The efficacy was assessed using total PANSS, and adverse effects using total UKU, during one‐year follow‐up. We used the Klm3D method to cluster longitudinal data. Results: We identified four clusters: cluster A, drug not toxic and beneficial; cluster B, drug beneficial but toxic; cluster C, drug neither toxic nor beneficial; and cluster D, drug toxic and not beneficial. These groups significantly differ in baseline demographics, clinical, and neuropsychological characteristics (PAS, total PANSS, DUP, insight, pIQ, age of onset, cocaine use and family history of mental illness). Conclusions: The results presented here allow the identification of phenotypes of AP response that differ in well‐known simple and classic clinical variables opening the door to clinical prediction and application of personalized medicine. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Acta Psychiatrica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=143634107 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/acps.13131 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 12 StartPage: 541 Subjects: – SubjectFull: Individualized medicine Type: general – SubjectFull: Psychoses Type: general – SubjectFull: Phenotypes Type: general – SubjectFull: Age of onset Type: general – SubjectFull: Mental illness Type: general Titles: – TitleFull: Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mas, S. – PersonEntity: Name: NameFull: Gassó, P. – PersonEntity: Name: NameFull: Rodríguez, N. – PersonEntity: Name: NameFull: Cabrera, B. – PersonEntity: Name: NameFull: Mezquida, G. – PersonEntity: Name: NameFull: Lobo, A. – PersonEntity: Name: NameFull: González‐Pinto, A. – PersonEntity: Name: NameFull: Parellada, M. – PersonEntity: Name: NameFull: Corripio, I. – PersonEntity: Name: NameFull: Vieta, E. – PersonEntity: Name: NameFull: Castro‐Fornieles, J. – PersonEntity: Name: NameFull: Bobes, J. – PersonEntity: Name: NameFull: Usall, J. – PersonEntity: Name: NameFull: Saiz‐Ruiz, J. – PersonEntity: Name: NameFull: Contreras, F. – PersonEntity: Name: NameFull: Parellada, E. – PersonEntity: Name: NameFull: Bernardo, M. – PersonEntity: Name: NameFull: Lafuente, Amalia – PersonEntity: Name: NameFull: Bioque, Miquel – PersonEntity: Name: NameFull: Diaz‐Caneja, Covadonga M. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 0001690X Numbering: – Type: volume Value: 141 – Type: issue Value: 6 Titles: – TitleFull: Acta Psychiatrica Scandinavica Type: main |
| ResultId | 1 |